Cardiomyopathy_Paediatric
Gene: FHL1
PMID 42304238: reviewed 114 patients with pathogenic or likely pathogenic FHL1 variants. Most patients were male (69%), with a median age of onset of 18 (IQR 10-26) years. Cardiac involvement consisted in left ventricular hypertrophy (56%), followed by arrhythmias (51%), and conduction abnormalities (8%). The incidence of sudden cardiac death was 7%, and heart transplantation was reported in 5% of patients.Created: 5 Sep 2026, 1:57 p.m. | Last Modified: 5 Sep 2026, 1:57 p.m.
Panel Version: 1.235
HCM is part of the phenotype.
Sources: Expert listCreated: 5 Aug 2020, 6:18 p.m.
Mode of inheritance
X-LINKED: hemizygous mutation in males, biallelic mutations in females
Phenotypes
Emery-Dreifuss muscular dystrophy 6, X-linked, MIM# 300696
Publications
Gene: fhl1 has been classified as Green List (High Evidence).
Phenotypes for gene: FHL1 were changed from to Emery-Dreifuss muscular dystrophy 6, X-linked, MIM# 300696
Publications for gene: FHL1 were set to http://www.ncbi.nlm.nih.gov/pubmed/22523091
gene: FHL1 was added gene: FHL1 was added to Cardiomyopathy_Paediatric. Sources: NHS GMS,South West GLH,Expert Review Green Mode of inheritance for gene: FHL1 was set to X-LINKED: hemizygous mutation in males, biallelic mutations in females Publications for gene: FHL1 were set to http://www.ncbi.nlm.nih.gov/pubmed/22523091